Equity
€118,230 ▼ 49.4%
DR.CIUCIULETE paid out €120,833 in dividends. That is 2,222% of the 2025 profit.
DR.CIUCIULETE
Lifetime
18 annual accounts with figures on one time axispeak €175,108 (2008)
€156,365▲ 20.0%
peak €103,902 (2008)
€5,438▼ 38.3%
peak €344,258 (2014)
€118,230▼ 49.4%
€349,185▲ 161%
Board1 name since 2021
1 directorCIUCIULETE Anca
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €130,343 to €156,365Result from €8,818 to €5,438Dividend €120,833Equity from €233,625 to €118,230Debts from €133,573 to €349,185
Key points
from the 2025 annual accountsChecked score
87
Excellent
Financially stronger than 29% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.1%▼ -0.1 percentage points vs 04-2025
06-2025: 0.2%▲ +0.1 percentage points vs 05-2025
07-2025: 0.2%● unchanged vs 06-2025
08-2025: 0.3%▲ +0.1 percentage points vs 07-2025
09-2025: 0.3%● unchanged vs 08-2025highest value
10-2025: 0.1%▼ -0.2 percentage points vs 09-2025lowest value
11-2025: 0.1%● unchanged vs 10-2025lowest value
12-2025: 0.1%● unchanged vs 11-2025lowest value
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.1%● unchanged vs 04-2026
06-2026: 0.1%● unchanged vs 05-2026
07-2026: 0.1%● unchanged vs 06-2026
08-2026: 0.2%▲ +0.1 percentage points vs 07-2026
09-2026: 0.2%● unchanged vs 08-2026
10-2026: 0.2%● unchanged vs 09-2026
11-2026: 0.2%● unchanged vs 10-2026
Financial strengthWeak
Score breakdown
raises risk
Last filed accounts filed 28 days late; 2 of the last 3 accounts late
lowers risk
Size: total assets €467,415
Liquidity: current ratio 1.23, cash €180,735
No main activity registered
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 30% of them on solvency, 54% on liquidity, 21% on profitability and 9% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 4,107 companies had the same profile as DR.CIUCIULETE has now. Each dot stands for 11 companies, two years later.
98.0%
were still trading
0.9%
stopped another way
1.0%
went bankrupt
Another 0.2% stopped without a precise date, possibly only after those two years.
That fits the bankruptcy probability of DR.CIUCIULETE itself: 0.2% within 12 months.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 4,107 companies, not a prediction for DR.CIUCIULETE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.23 (2.37 in 2024), below the usual 1.5. Short-term debt is 74.7% and cash 38.7% of total assets. 74.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises risk
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
28 days late
2024
31 days late
2023
31 days late
2022
29 days late
2021
31 days late
2020
31 days late
2019
28 days late
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 7 accounts on average 30 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
06-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Reappointment: CIUCIULETE Anca (director)
General meeting of 08-09-2026 · Gazette deed
First establishment
Rue du Calvaire 22, Gerpinnes
Incorporation
published on 04-12-2007 · Gazette deed
Official details
Source: KBO- Status
- Active since 23-11-2007Normal situation
- Activity
- “En assurant la gestion d'un centre médical ou d'un cabinet médical, en ce compris…” (deed in French)From the articles, 7 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.303.799.6866280 Gerpinnes, since 04-12-2007
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Insights on DR.CIUCIULETE
DR.CIUCIULETE files the micro format. That format states no turnover. The gross margin fell from €175,108 in 2008 to €156,365 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DR.CIUCIULETE
- What is the company number of DR.CIUCIULETE?
- The company number of DR.CIUCIULETE is 0893.693.662. The VAT number is the same number with BE in front: BE 0893.693.662.
- Where is DR.CIUCIULETE based?
- The registered office is at Rue du Calvaire 22, 6280 Gerpinnes.Company details
- What is the legal form of DR.CIUCIULETE?
- DR.CIUCIULETE is a private limited company (BV).
- When was DR.CIUCIULETE founded?
- DR.CIUCIULETE was founded on 23-11-2007.
- Is DR.CIUCIULETE still active?
- Yes, DR.CIUCIULETE is an active enterprise in the KBO register.
- What is the turnover of DR.CIUCIULETE?
- The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €156,365 and 2,211 comparable companies of the same size. It probably lies between €260,000 and €600,000. It is a rough estimate.Financials
- Is DR.CIUCIULETE profitable?
- In financial year 2025, DR.CIUCIULETE made a profit of €5,438.
- Where can I find the annual accounts of DR.CIUCIULETE?
- DR.CIUCIULETE filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of DR.CIUCIULETE due?
- DR.CIUCIULETE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.